GH Research (GHRS) Cash from Investing Activities Growth (1y) (2022 - 2025)
GH Research (GHRS) Cash from Investing Activities Growth (1y) (2022 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Investing Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
-114.28% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
826.39% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
-674.01% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
GH Research |
10.10 Bn |
10.00 Bn |
- |
-58.56% |
| Date | Value |
|---|
| Dec 31, 2025 |
-58.56% |
| Sep 30, 2025 |
-35.99% |
| Jun 30, 2025 |
-20.38% |
| Mar 31, 2025 |
34.71% |
| Dec 31, 2024 |
88,979.17% |
| Sep 30, 2024 |
191,150.00% |
| Jun 30, 2024 |
42,995.65% |
| Mar 31, 2024 |
116.27% |
| Dec 31, 2023 |
99.97% |
| Sep 30, 2023 |
46.67% |
| Jun 30, 2023 |
-91.67% |
| Mar 31, 2023 |
-540,120.00% |
| Dec 31, 2022 |
-445,368.42% |
| Sep 30, 2022 |
70.00% |
| Jun 30, 2022 |
-71.43% |
| Mar 31, 2022 |
52.38% |
